Vibrio cholerae (ATCC® 55859)

Strain Designations: Bah-2  /  Type Strain: no  /  Biosafety Level: 2

Classification Eltor biovar
Strain Designations Bah-2
Application
Transformation host
Used to produce attenuated vaccine strain against cholera
Enteric Research
Waterborne pathogen research
Isolation
Mutant derived from E7946-Sm, ATCC 55332
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype Inaba (Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997)
Product Format freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol® no
Type Strain no
Antigenic Properties Serotype Inaba (Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997)
Antibiotic Resistance
Resistant to streptomycin
Sensitive to kanamycin
Comments
Attenuated vaccine strain which expresses the B subunit, but not the A subunit
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor Harvard Medical School, JJ Mekalanos, Harvard Medical School
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation
Mutant derived from E7946-Sm, ATCC 55332
References

Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997

Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997

Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997